SEC Form D · Amendment · filed February 3, 2017
Transplant Genomics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Paul M. Sherman · Boston, MAExecRoy First · Mansfield, MAExecDudley Mcdaniel · Los Alamos, NMExecStanley Rose · Mansfield, MAExec · DirectorJames S. Newman · Cupar, United KingdomExecRosie Moore · VANCOUVER, British Columbia, CanadaDirectorDarren Lee · Mansfield, MAExecMichael Abecassis · Mansfield, MADirectorJason Mancuso · PORTLAND, ORDirectorLarry B. Donaldson · VANCOUVER, British Columbia, CanadaExec · DirectorHarshil Mathur · Palo Alto, CAExecGraham Downs · VANCOUVER, British Columbia, CanadaExecAndrew M. Weiss · Boston, MAExec · DirectorDylan Arnold-Wallinger · VANCOUVER, British Columbia, CanadaExecPeter Lewis · Mansfield, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗